DESIGN, SYNTHESIS, AND ANTIMYCOBACTERIAL EVALUATION OF NOVEL PYRROLE-OXADIAZOLE MOLECULAR HYBRID AGAINST MYCOBACTERIUM TUBERCULOSIS
DOI:
https://doi.org/10.22159/ajpcr.2026v19i1.56941Keywords:
Molecular hybrid of pyrrole with oxadiazole, Antitubercular agent, MABA Assay, Molecular docking, Lipinskii rule of 5Abstract
Objective: To enhance the potency of susceptible Mycobacterium tuberculosis (MTB) and create novel derivatives for multidrug-resistant tuberculosis with a molecular hybrid of pyrrole with oxadiazole.
Methods: A number of pyrrole-ligated oxadiazole molecular hybrid derivatives have been developed and produced in response to the bioisosteric similarities between isoniazid and pyrazinamide. Fourier transform infrared spectral data, mass spectrometry, and nuclear magnetic resonance were used to identify the target chemicals. The toxicity of the chosen ligands was assessed using human dermal fibroblast cell lines, and the in vitro Microplate Blue Alamar assay for antitubercular action of all the prepared compounds against the strain MTB H37Rv was assessed.
Results: Every developed drug exhibited MTB inhibition, with a minimum inhibitory concentration (MIC) ranging from 3.12 to 50 μM. OP3 was the most effective MTB inhibitor among the drugs evaluated (MIC=3.12 μM).
Conclusion: The current study’s findings indicate that the majority of the synthesized compounds exhibit an adequate range of molecular characteristics and are sensitive to MTB.
Downloads
References
1. World Health Organization. Global Tuberculosis Report 2024 and Global Tuberculosis Report; 2024. Available from: https://who.int [Last accessed on 2025 Aug 03].
2. Rabahi MF, Da Silva Júnior JL, Ferreira AC, Tannus-Silva DG, Conde MB. Tuberculosis treatment. J Bras Pneumol. 2017;43(6):472- 86. doi: 10.1590/S1806-37562016000000388, PMID 29340497
3. Davies PD, Yew WW. Recent developments in the treatment of tuberculosis. Expert Opin Investig Drugs. 2003;12(8):1297-312. doi: 10.1517/13543784.12.8.1297, PMID 12882618
4. Tiberi S, Muñoz-Torrico M, Duarte R, Dalcolmo M, D’Ambrosio L, Migliori GB. New drugs and perspectives for new anti-tuberculosis regimens. Pulmonology. 2018;24(2):86-98. doi: 10.1016/j. rppnen.2017.10.009, PMID 29487031
5. Asgaonkar KD, Mote GD, Chitre TS. QSAR and molecular docking studies of oxadiazole-ligated pyrrole derivatives as enoyl-ACP (CoA) reductase inhibitors. Sci Pharm. 2013;82(1):71-85. doi: 10.3797/ scipharm.1310-05, PMID 24634843
6. Kim H, Gu L, Yeo H, Choi U, Lee CR, Yu H, et al. Rapid assembly of pyrrole-ligated 1,3,4-oxadiazoles and excellent antibacterial activity of iodophenol substituents. Molecules. 2023;28(8):3638. doi: 10.3390/ molecules28083638, PMID 37110872
7. Long L, Zhang H, Zhou Z, Duan L, Fan D, Wang R, et al. Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and structure-activity relationships. Eur J Med Chem. 2024;273:116470. doi: 10.1016/j.ejmech.2024.116470, PMID 387629158. Kumar G, Kumar R, Mazumder A, Salahuddin, Kumar U. 1,3,4-oxadiazoles as anticancer agents: A review. Recent Pat Anticancer Drug Discov. 2024;19(3):257-67. doi: 10.2174/1574892818666230727 102928, PMID 37497702
9. Kumar Madugula A, Kiran B, Suresh Varma Dendukuri BN, Kishore TV, Srinivasa Rao P, Ranagaih G, et al. Synthesis, characterization, and evaluation of antioxidant, antimicrobial and drug likeness properties of indole containing 1,3,4-oxadiazoles. Results Chem. 2024;9:101664. doi: 10.1016/j.rechem.2024.101664
10. Abd El-Hameed RH, Sayed AI, Mahmoud Ali S, Mosa MA, Khoder ZM, Fatahala SS. Synthesis of novel pyrroles and fused pyrroles as antifungal and antibacterial agents. J Enzyme Inhib Med Chem. 2021;36(1):2183-98. doi: 10.1080/14756366.2021.1984904, PMID 34602000
11. Zidar N, Macut H, Tomašič T, Peterlin Mašič LP, Ilaš J, Zega A, et al. New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors. MedChemComm. 2019;10(6):1007-17. doi: 10.1039/c9md00224c, PMID 31303999
12. Gao Q, Liu S, Wu X, Zhang J, Wu A. Direct annulation of hydrazides to 1,3,4-oxadiazoles via oxidative C(CO)-C(Methyl) bond cleavage of methyl ketones. Org Lett. 2015;17(12):2960-3. doi: 10.1021/acs. orglett.5b01241, PMID 26035338
13. Dhakshinamoorthy A, Alvaro M, Garcia H. Claisen-Schmidt condensation catalyzed by metal-organic frameworks. Adv Synth Catal. 2010;352(4):711-7. doi: 10.1002/adsc.200900747
14. Shafi SS, Rajesh R, Senthilkumar S. Synthesis and characterization of boc-protected thio-1,3,4-oxadiazol-2-yl derivatives. Int J Chem Res. 2021;5(3):5-10. doi: 10.22159/ijcr.2021v5i3.169
15. Kachkurea D, Dhawale SA, Tapadiya G, Pawar C, Bharad J. Synthesis and evaluation of diazo-triazole hybrid as anti-tubercular agents. Int J Chem Res. 2025;9(4):34-9.
16. Sunil D, D’Almeida L, Kini SG, Rama M. Synthesis of quinolinyl-oxadiazole as a potent antibacterial agent and sa-fabi inhibitor. Int J Pharm Pharm Sci. 2015;7(8):105-9.
17. Joshi SD, Dixit SR, Kirankumar MN, Aminabhavi TM, Raju KV, Narayan R, et al. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties. Eur J Med Chem. 2016;107:133-52. doi: 10.1016/j.ejmech.2015.10.047, PMID 26580979
18. Biradar SM, Mote GD, Asgaonkar KD, Chitre TS. Synthesis, docking and biological evaluation of pyrrole-2-carbohydrazide derivatives. Pharm Chem. 2015;7(2):153-9.
19. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate alamar blue assay. J Clin Microbiol. 1998;36(2):362-6. doi: 10.1128/ jcm.36.2.362-366.1998, PMID 9466742
20. Meyer K, Rajanahalli P, Ahamed M, Rowe JJ, Hong Y. ZnO nanoparticles induce apoptosis in human dermal fibroblasts via p53 and p38 pathways. Toxicol In Vitro. 2011;25(8):1721-6. doi: 10.1016/j. tiv.2011.08.011, PMID 21903158
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63. doi: 10.1016/0022-1759(83)90303-4, PMID 6606682
22. Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-61. doi: 10.1002/ jcc.21334, PMID 19499576
23. O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open babel: An open chemical toolbox. J Cheminform. 2011;3(1):33. doi: 10.1186/1758-2946-3-33, PMID 21982300
24. RCSB Protein Data Bank. PDB ID: 3H7A; 2024. Available from: https://www.rcsb.org/structure/3ha7 [Last accessed on 2025 Aug 01].
25. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1-3):3-26. doi: 10.1016/s0169-409x(00)00129-0, PMID 11259830
26. Drug-Likeness and Molecular Property Prediction. Available from: https://www.swissadme.ch [Last accessed on 2025 Aug 03].
Published
How to Cite
Issue
Section
Copyright (c) 2025 Ganesh Mote, Dr. Mahesh Saralaya
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.